Cargando…
AAV-based Gene Therapy Prevents Neuropathology and Results in Normal Cognitive Development in the Hyperargininemic Mouse
Complete arginase I deficiency is the least severe urea cycle disorder, characterized by hyperargininemia and infrequent episodes of hyperammonemia. Patients suffer from neurological impairment with cortical and pyramidal tract deterioration, spasticity, loss of ambulation, and seizures, and is asso...
Autores principales: | Lee, Eun K., Hu, Chuhong, Bhargava, Ragini, Ponnusamy, Ravi, Park, Hana, Novicoff, Sarah, Rozengurt, Nora, Marescau, Bart, De Deyn, Pater, Stout, David, Schlichting, Lisa, Grody, Wayne W., Cederbaum, Stephen D., Lipshutz, Gerald S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679314/ https://www.ncbi.nlm.nih.gov/pubmed/23388701 http://dx.doi.org/10.1038/gt.2012.99 |
Ejemplares similares
-
Minimal Ureagenesis is Necessary for Survival in the Murine Model of Hyperargininemia Treated by AAV-based Gene Therapy
por: Hu, Chuhong, et al.
Publicado: (2014) -
AAV-based Neonatal Gene Therapy for Hemophilia A: Long-Term Correction and Avoidance of Immune Responses in Mice
por: Hu, Chuhong, et al.
Publicado: (2012) -
Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers
por: Eno, Celeste C., et al.
Publicado: (2019) -
Homeostatic Plasticity of Striatal Neurons Intrinsic Excitability following Dopamine Depletion
por: Azdad, Karima, et al.
Publicado: (2009) -
Augmentation of Transgene-Encoded Protein After Neonatal Injection of
Adeno-Associated Virus Improves Hepatic Copy Number Without Immune
Responses
por: Tai, Denise S., et al.
Publicado: (2015)